Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prostaglandin E2 Regulates the Complement Inhibitor CD55/Decay-accelerating Factor in Colorectal Cancer
Vijaykumar Holla, Dingzhi Wang, Joanne R. Brown, et al.
Journal of Biological Chemistry (2004) Vol. 280, Iss. 1, pp. 476-483
Closed Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Nuclear factor-κB in cancer development and progression
Michael Karin
Nature (2006) Vol. 441, Iss. 7092, pp. 431-436
Closed Access | Times Cited: 3370
PROSTAGLANDINS AND CANCER
Diandian Wang
Gut (2005) Vol. 55, Iss. 1, pp. 115-122
Open Access | Times Cited: 864
Cox-2 Is Regulated by Toll-Like Receptor-4 (TLR4) Signaling: Role in Proliferation and Apoptosis in the Intestine
Masayuki Fukata, Anli Chen, Arielle Klepper, et al.
Gastroenterology (2006) Vol. 131, Iss. 3, pp. 862-877
Open Access | Times Cited: 443
NF‐κB and cancer: Mechanisms and targets
Michael Karin
Molecular Carcinogenesis (2006) Vol. 45, Iss. 6, pp. 355-361
Closed Access | Times Cited: 287
Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways
Maya R. MacLean, Olivia L. Walker, Raj Pranap Arun, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4102-4102
Open Access | Times Cited: 15
Liposomal dexamethasone–diclofenac combinations for local osteoarthritis treatment
Inbar Elron-Gross, Yifat Glucksam, Rimona Margalit
International Journal of Pharmaceutics (2009) Vol. 376, Iss. 1-2, pp. 84-91
Closed Access | Times Cited: 92
Prostaglandin E2 Regulates the Nuclear Receptor NR4A2 in Colorectal Cancer
Vijaykumar Holla, Jason R. Mann, Qiong Shi, et al.
Journal of Biological Chemistry (2005) Vol. 281, Iss. 5, pp. 2676-2682
Open Access | Times Cited: 116
Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin
Anne Kinderlerer, Isabel Pombo Grégoire, Shahir Hamdulay, et al.
Blood (2008) Vol. 113, Iss. 7, pp. 1598-1607
Open Access | Times Cited: 82
CD55 in cancer: Complementing functions in a non-canonical manner
Rashmi Bharti, Goutam Dey, Feng Lin, et al.
Cancer Letters (2022) Vol. 551, pp. 215935-215935
Open Access | Times Cited: 26
Possible Involvement of RUNX3 Silencing in the Peritoneal Metastases of Gastric Cancers
Chouhei Sakakura, Kazunori Hasegawa, Koji Miyagawa, et al.
Clinical Cancer Research (2005) Vol. 11, Iss. 18, pp. 6479-6488
Closed Access | Times Cited: 73
Inhibition of Decay-Accelerating Factor (CD55) Attenuates Prostate Cancer Growth and Survival In Vivo
Robert D. Loberg, LaShon L. Day, Rodney L. Dunn, et al.
Neoplasia (2006) Vol. 8, Iss. 1, pp. 69-78
Open Access | Times Cited: 71
Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack In Vitro
Nicolas A. Geis, S. Zell, R. Rutz, et al.
Current Cancer Drug Targets (2010) Vol. 10, Iss. 8, pp. 922-931
Closed Access | Times Cited: 64
Artesunate exerts an anti‐immunosuppressive effect on cervical cancer by inhibiting PGE2 production and Foxp3 expression
Lixin Zhang, Zhineng Liu, Jun Ye, et al.
Cell Biology International (2014) Vol. 38, Iss. 5, pp. 639-646
Closed Access | Times Cited: 43
Increased Susceptibility to Complement Attack due to Down-Regulation of Decay-Accelerating Factor/CD55 in Dysferlin-Deficient Muscular Dystrophy
Katrin Wenzel, Joanna Zabojszcza, Miriam Carl, et al.
The Journal of Immunology (2005) Vol. 175, Iss. 9, pp. 6219-6225
Open Access | Times Cited: 69
Blockade of bulky lymphoma‐associated CD55 expression by RNA interference overcomes resistance to complement‐dependent cytotoxicity with rituximab
Yasuhito Terui, Takuma Sakurai, Yuko Mishima, et al.
Cancer Science (2005) Vol. 97, Iss. 1, pp. 72-79
Open Access | Times Cited: 60
Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer.
Christina Lönnroth, Marianne Andersson, Annette Arvidsson, et al.
PubMed (2008)
Closed Access | Times Cited: 59
The Role of Membrane Complement Regulatory Proteins in Cancer Immunotherapy
Jun Yan, Daniel J. Allendorf, Bing Li, et al.
Advances in experimental medicine and biology (2008), pp. 152-167
Closed Access | Times Cited: 56
Membrane-bound complement regulatory proteins are prognostic factors of operable breast cancer treated with adjuvant trastuzumab: A retrospective study
Mei Liu, Yajun Yang, Hong Zheng, et al.
Oncology Reports (2014) Vol. 32, Iss. 6, pp. 2619-2627
Open Access | Times Cited: 39
A functional SNP in the regulatory region of the decay-accelerating factor gene associates with extraocular muscle pareses in myasthenia gravis
Jeannine M. Heckmann, Henriette Uwimpuhwe, Robea Ballo, et al.
Genes and Immunity (2009) Vol. 11, Iss. 1, pp. 1-10
Open Access | Times Cited: 39
Runx1 is a tumor suppressor gene in the mouse gastrointestinal tract
Remond J.A. Fijneman, Rebecca Anderson, Ethan Richards, et al.
Cancer Science (2011) Vol. 103, Iss. 3, pp. 593-599
Open Access | Times Cited: 38
Decay-accelerating factor (CD55): A versatile acting molecule in human malignancies
Jan‐Henrik Mikesch, Horst Buerger, Ronald Simon, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2006) Vol. 1766, Iss. 1, pp. 42-52
Closed Access | Times Cited: 46
PGE<sub>2</sub>-induced Apoptotic Cell Death in K562 Human Leukaemia Cells
Michael Föller, Ravi S. Kasinathan, Christophe Duranton, et al.
Cellular Physiology and Biochemistry (2006) Vol. 17, Iss. 5-6, pp. 201-210
Open Access | Times Cited: 45
HEF1 Is a Crucial Mediator of the Proliferative Effects of Prostaglandin E2 on Colon Cancer Cells
Dianren Xia, Vijaykumar Holla, Dingzhi Wang, et al.
Cancer Research (2010) Vol. 70, Iss. 2, pp. 824-831
Open Access | Times Cited: 30
Prostaglandin E2 Affects T Cell Responses through Modulation of CD46 Expression
Karoline Kickler, Kathryn Maltby, Siobhán Ní Choileáin, et al.
The Journal of Immunology (2012) Vol. 188, Iss. 11, pp. 5303-5310
Open Access | Times Cited: 26
Receptors and Host Factors for Enterovirus Infection: Implications for Cancer Therapy
Olga N. Alekseeva, Le Thi Kim Hoa, Pavel O. Vorobyev, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3139-3139
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top